AMSTERDAM, Netherlands, July 11 /PRNewswire/ -- KREATECH Biotechnology BV and Funakoshi from Japan today announced a partnership whereby Funakoshi will exclusively supply KREATECH’s ULS(TM) solutions to laboratories in Japan. The partnership will expand life science investigators in Japan access to innovative non-enzymatic nucleic acid & protein labeling solutions.
KREATECH’s Universal Linkage System (ULS(TM)) allows for the rapid attachment of a variety of labels directly to DNA, RNA and proteins. These products are centered around a proprietary platinum-based system that produces highly stable labels under a wide variety of conditions. The ULS(TM) products are available with a wide variety of industry standard dyes, offering a versatile solution for the labeling of RNA in microarray and DNA in CGH applications.
“This agreement expands our reach by leveraging Japan strong sales and marketing team in Japan” said Alex Altink, KREATECH’s CEO. “We look forward to working with Funakoshi and expanding our international distribution network. This month we closed similar agreements with BIOKE for the Benelux, Open Biosystems for the USA and with Essen-Haus for the Malaysian market. In the next coming month’s we expect to expand our distribution network furthermore, both in Europe and Asia.”
“This agreement will make further advancement for molecular biology and drug discovery in Japan. We are very glad to conclude a partnership with KREATCH, who has a very innovative labeling technology” said Dr. Ryoya Funakoshi, President and CEO of Funakoshi.
About KREATECH Biotechnology
KREATECH Biotechnology B.V., a private company founded in 1990, focuses on the creation, development, production and marketing of innovative diagnostic and life science products. KREATECH’s proprietary Universal Linkage System (ULS(TM)) offers a reliable, robust and easy to use non-enzymatic technology that can be applied to a broad range of biomolecules and labeling agents. KREATECH is committed to achieve and maintain the highest standards in production and Quality Control as well as in the relationships with our customers and partners. The company’s quality policies are demonstrated by the implementation of ISO 9001 (2000) and ISO 13485 (GMP 2003) guidelines. More information on KREATECH can be accessed at www.kreatech.com
About Funakoshi
Funakoshi Co., Ltd. has contributed as a leader to distribute research reagents and instruments for researchers in life science fields since its foundation. The mission of Funakoshi is offering many useful tools with leading edge technologies for Japanese researchers from all over the world to support and develop their research. For more information, visit Funakoshi’s website: www.funakoshi.co.jp
Kreatech Biotechnology B.V.
CONTACT: Media contact: Brent Keller, Kreatech Biotechnology BV,+1-(858)-794-0226, b.keller@kreatech.com; Contact: Technical support,Funakoshi Co., Ltd., +81-3-5684-1620, reagent@funakoshi.co.jp
